Tag archive for ‘Sanofi Pasteur’
By The Dispatch On Friday, June 20th, 2014

Gardasil approved for the prevention of anal cancer in Europe

  Sanofi Pasteur MSD announced Wednesday that the European Commission has granted marketing authorisation for the use of Gardasil for the prevention of anal precancerous lesions and anal cancers causally related More...

By The Dispatch On Wednesday, April 2nd, 2014

FDA lowers age indication for Sanofi Pasteur’s Adacel Tdap vaccine

PRESS RELEASE Sanofi Pasteur, the vaccines division of Sanofi , announced Tuesday that the U.S. Food and Drug Administration (FDA) has expanded the approved age indication of Adacel® (Tetanus Toxoid, Reduced Diphtheria More...

By Robert Herriman On Thursday, March 7th, 2013
1 Comment

CDC reports on rabies vaccine availability; doxycycline, tetracycline shortages

In a Centers for Disease Control and Prevention bulletin Thursday, officials report that restrictions on the use of Sanofi Pasteur’s IMOVAX rabies vaccine are still in effect. Photo/CDC/ Debora Cartagena IMOVAX More...

By Robert Herriman On Monday, January 14th, 2013

Inviragen CEO, Dr. Dan Stinchcomb gives an update on the DENVax dengue fever vaccine

Photo/CDC/ Debora Cartagena It’s in the news on a regular basis these days, a dengue fever outbreak here, an epidemic there, even Europe experienced their first sustained transmission of dengue since the 1920′s More...

By Robert Herriman On Thursday, October 4th, 2012

Sanofi Pasteur announces recall of typhoid vaccine

Sanofi Pasteur, the vaccines division of Sanofi, has announced that it is voluntarily recalling several batches of its typhoid fever vaccine, TYPHIM Vi®, due to concerns that the doses may not provide the intended More...


Splash Page logo 300x146 Today in History